Mrs Lindsey Patricia Schmelzer, | |
307 Boatner Rd Ste 114, Eglin Afb, FL 32542-1302 | |
(850) 883-8132 | |
Not Available |
Full Name | Mrs Lindsey Patricia Schmelzer |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 307 Boatner Rd Ste 114, Eglin Afb, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467826545 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mrs Lindsey Patricia Schmelzer, 307 Boatner Rd Ste 114, Eglin Afb, FL 32542-1302 Ph: (850) 883-8132 | Mrs Lindsey Patricia Schmelzer, 307 Boatner Rd Ste 114, Eglin Afb, FL 32542-1302 Ph: (850) 883-8132 |
News Archive
A new national survey reveals a vast gap between how Canadians living with depression view their condition, compared to how it is viewed in reality by the general population, possibly preventing them from seeking the best treatment and care. Most Canadians with depression feel their illness is not perceived by the public as a medical condition or a serious illness (81 per cent) when in fact less than five per cent of the general population actually has that view. In fact, the majority of Canadians (72 per cent) recognize depression as both serious and treatable.
News-Medical Life Sciences spoke to Nicholas Dupuis from Biognosys about proteomics & DIA mass spectrometry in neurodegenerative disease research.
Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $1.35 million federal grant to study how emulsifiers affect bacteria in the intestinal tract and cause chronic inflammatory diseases in the gut.
Cyterix Pharmaceutics, Inc. announced today that the company has raised $9.2 million in a Series A financing from The Column Group and SV Life Sciences. Cyterix is developing novel cancer therapeutics based on a prodrug approach that targets extra-hepatic cytochrome P450 enzymes that are over-expressed in many cancers to a high frequency, but not in normal tissues.
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
› Verified 8 days ago